1.Late Bone Metastasis of Histologically Bland Struma Ovarii: The Unpredictability of Its Biologic Behavior.
Sun Ju OH ; Minjung JUNG ; Young Ok KIM
Journal of Pathology and Translational Medicine 2015;49(4):343-345
No abstract available.
Neoplasm Metastasis*
;
Struma Ovarii*
2.A Case of Struma Ovarii.
Ji Hye SHIN ; Hyun Ju PARK ; Moon Jung KIM ; Mi Kyung KIM ; Hyun Ju SEOL ; Hee Jin KIM ; Eun Kyu KIM ; Won Young CHOI
Korean Journal of Obstetrics and Gynecology 2003;46(6):1218-1221
Struma ovarii is a monodermal and highly specialized teratoma which is composed predominantly or entirely of thyroid tissue. It is rare tumor accounting for 2.7% of ovarian mature cystic teratoma. Most of the tumors are benign. Malignant change has been reported in approximately 5% of cases. We have experienced a case of struma ovarii with brief review of the literature.
Struma Ovarii*
;
Teratoma
;
Thyroid Gland
3.A Case of Struma Ovarii.
Jong Sung PARK ; Mi Lyong KIM ; Ho Ju YOUN ; Hyum Ah JUN ; Jau Gu JONG
Korean Journal of Obstetrics and Gynecology 1997;40(7):1538-1541
Struma ovarii is a highly specilized form of mature cystic teratoma of the ovary. It is extremely rare and accounts for only 2.7% of all ovarian teratomas. When thyroid tissue constitutes more than 50% of the tumor, it is usually called a struma ovarii. We reproted a case of struma ovarii and review the literature concerning this tumor briefly.
Female
;
Ovary
;
Struma Ovarii*
;
Teratoma
;
Thyroid Gland
4.Follicular Proliferative Lesion Arising in Struma Ovarii.
Min Jee PARK ; Min A KIM ; Mi Kyung SHIN ; Hye Sook MIN
Journal of Pathology and Translational Medicine 2015;49(3):262-266
Malignant struma ovarii is extremely rare and difficult to diagnose histologically, particularly in cases of follicular carcinoma. This case study is intended to describe three cases of follicular proliferative lesion arising in struma ovarii that we experienced. The first case was clearly malignant given the clinical picture of multiple recurrences, but there was little histological evidence of malignancy. Our second case featured architectural and cellular atypia and necrosis and was diagnosed as malignant despite the absence of vascular and stromal invasion. Our third case exhibited solid microfollicular proliferation without any definite evidence of malignancy (even the molecular data was negative); however, we could not completely exclude malignant potential after conducting a literature review. In cases such as our third case, it has been previously suggested that a diagnostic term recognizing the low-grade malignant potential, such as "proliferative stromal ovarii" or "follicular proliferative lesion arising in the stromal ovarii" would be appropriate.
Adenocarcinoma, Follicular
;
Necrosis
;
Recurrence
;
Struma Ovarii*
5.Coexisting brenner tumor and struma ovarii in the unilateral ovary; A case report.
Dong Uk LEE ; Mi Jin KIM ; Sung Chul PARK
Korean Journal of Obstetrics and Gynecology 2008;51(7):789-794
Co-existing Brenner tumor and struma ovarii in the unilateral ovary is very rare. The present case, which is the first case in Korea, and to our knowledge only nine cases had been reported in other countries. We report a case of 42-year-old woman who had co-existing Brenner tumor and struma ovarii in the unilateral ovary with a brief review of the literature.
Adult
;
Brenner Tumor
;
Female
;
Humans
;
Korea
;
Ovary
;
Struma Ovarii
6.A Case of Malignant Struma Ovarii.
Sang Yun OH ; Jae Hong NOH ; Chel Hun CHOI ; Ui Young LEE ; Chang Soo PARK ; Duk Soo BAE ; Je Ho LEE ; Byong Gie KIM
Korean Journal of Obstetrics and Gynecology 2002;45(10):1856-1859
Struma Ovarii is a teratoma with thyroid tissue as the predominant (>50%) constituent. It is rare, representing about 2% of all teratomas, and its malignant transformation, less than 5% of struma ovarii. Presenting symptoms are not specific, therefore pre-operative diagnosis of malignant struma ovarii is difficult and most diagnosis of malignant struma ovaii is determined by post-operative histologic findings. Because of the rarity of malignant struma ovarii, there is considerable confusion concerning diagnosis and management. A postmenopausal woman presented with pelvic mass and lower abdominal pain and explo-laparotomy was performed. Then, pathologic report was identified as malignant struma ovarii. We report a case of malignant struma ovarii with brief review of literature
Abdominal Pain
;
Diagnosis
;
Female
;
Humans
;
Struma Ovarii*
;
Teratoma
;
Thyroid Gland
7.MR Findings of Malignant Struma Ovarii Associated with Mature Cystic Teratoma of Contralateral Ovary: Case Report.
Journal of the Korean Radiological Society 2003;49(4):311-313
Malignant struma ovarii is a rare form of ovarian carcinoma. Sincc it is often seen as a nonspecific complex mass, its preoperative diagnosis is difficult. The MR imaging findings of benign struma ovarii have been reported, but no published account has described the malignant form. In this case, MR images depicted multiple cysts with well enhanced solid portions in the left ovary, and the typical apperarance of mature cystic teratoma in the right ovary. We describe a case of malignant struma ovarii associated with mature cystic teratoma of the contralateral ovary.
Diagnosis
;
Female
;
Magnetic Resonance Imaging
;
Ovary*
;
Struma Ovarii*
;
Teratoma*
8.Two Cases of Struma Ovarii.
Jin Young CHANG ; Kab In CHUNG ; Kae Hyun NAM ; Kwon Hae LEE ; Dong Won KIM
Korean Journal of Gynecologic Oncology and Colposcopy 1998;9(1):87-92
Struma ovarii is a monodermal teratoma composed totally or in overwhelming proportion of thyroid tissue. It is uncommon and accounts for 1% to 3% of benign teratomas of ovary. Grossly, they are encapsulated neoplasms, several centimeters in diameter and have a red, shiny, and meaty surface. Microscopically, the tumor is composed of mature thyroid tissue consisting of various sizes, lined by a single layer of columnar or flattened epithelium. The clinical behavior is benign, and simple excision is adequate treatment. We had experienced two cases of struma ovarii arising in the left ovaries. So we report above cases with brief review of literatures.
Epithelium
;
Female
;
Ovary
;
Struma Ovarii*
;
Teratoma
;
Thyroid Gland
9.Risk factors for malignant transformation of mature cystic teratoma.
Chan Hong PARK ; Min Hyung JUNG ; Yong Il JI
Obstetrics & Gynecology Science 2015;58(6):475-480
OBJECTIVE: The aim of this study was to investigate the preoperative characteristics of benign mature cystic teratoma (MCT) and struma ovarii and their risk factors associated malignancies, and determine the appropriate treatment options for these tumors. METHODS: This was a retrospective study on 248 patients who were pathologically diagnosed with ovarian MCT, struma ovarii, or malignant transformations of these tumors at Inje University Haeundae Paik Hospital from March 2010 to January 2015. Routinely evaluated results of adnexal masses before surgery were compared. RESULTS: A total of six patients (2.4%) were confirmed to have malignant tumors. Of the struma ovarii patients, two out of five patients (40%) were confirmed to have malignancy. The mean age at the diagnosis of patients with malignant transformation of teratomas was 43.0 years (range, 27 to 67 years), which was higher than that of patients with benign teratomas (36.5 years). The mean diameter of the tumor before surgery in the malignant tumor group was 11.4 cm and larger than 6.5 cm of benign group (P=0.003). The mean CA-125 level in the malignant tumor group was higher than that in the benign tumor group (P=0.01). CONCLUSION: Risk factors for malignant transformation of MCT include elevated CA-125 levels, older age, large tumor masses, and postmenopausal status.
Diagnosis
;
Humans
;
Retrospective Studies
;
Risk Factors*
;
Struma Ovarii
;
Teratoma*
10.Struma ovarii-associated pseudo-Meigs−syndrome with concomitant abdominopelvic tuberculosis masquerading as ovarian malignancy
Nicole Anna Marie H. Dionisio ; Elizabeth K. Jacinto
Philippine Journal of Obstetrics and Gynecology 2021;45(6):244-249
Pseudo-Meigs' syndrome (PMS) is a rare disease characterized by the triad of (1) an ovarian neoplasm, other than a fibroma or thecoma, (2) ascites, and (3) pleural effusion. Tumors such as struma ovarii, mucinous and serous cystadenomas, and germ cell tumors have been linked with the condition. Due to its clinical features combined with the elevation of serum cancer antigen 125 (CA-125) levels, it is often mistaken and treated as a malignant ovarian tumor. Ascites or pleural effusion could be massive leading to various life-threatening complications. Despite its presentation, this entity has an excellent prognosis when surgical excision of the tumor is performed. This article presents an unusual case of a 41-year-old gravida 10 para 10 (10-0-0-9) who was diagnosed with a case of struma ovarii associated PMS with concomitant abdominopelvic tuberculosis and elevated CA-125 resembling an ovarian malignancy.
Ascites
;
Struma Ovarii
;
Meigs Syndrome
;
CA-125 Antigen
;
Abdominal Neoplasms